00:00:00 IGIHE NETWORK KN KINYARWANDA EN ENGLISH FR FRANCAIS

BioNTech igeze kure ikorwa ry’umuti wa kanseri

Yanditswe na Uwimana Abraham
Kuya 21 March 2024 saa 12:51
Yasuwe :

Uruganda rukora inkingo n’imiti rwa BioNTech rwo mu Budage, rwatangaje ko rugeze kure gahunda yo gukora umuti uvura kanseri zitandukanye, biteganyijwe ko uzatangira gukoreshwa mu 2026.

Uyu muti uri gukorwa hifashishijwe ikoranabuhanga rya Messenger RNA (mRNA), uburyo busanzwe bwifashishwa mu gukora inkingo zirimo n’urwa COVID-19.

Iri koranabuhanga rya Mrna rituma uwatewe umuti cyangwa urukingo bigera mu mubiri we bikawufasha kurema ubudahangarwa bugizwe n’abasirikare barwanya agakoko gatera iyo ndwara.

BioNTech yatangaje ko uyu muti uzashobora kuvura ubwoko bwa kanseri zitandukanye zirimo iy’uruhu, iya prostate, iy’umutwe cyangwa ijosi, iy’inkondo y’umura, iy’ibihaha, n’iy’amara.

Yanditse iti “Sosiyete ifite gahunda yo gukomeza gukora imishinga itandukanye izamurikwa mu 2026. Intego yacu ni ugukora umuti unoze wa kanseri kuri buri murwayi.”

Aho imariye kugurisha miliyoni z’inkingo za Covid, BioNTech yashoye amafaranga yakuyemo mu bushakashatsi bugendanye no gukora umuti wa kanseri, aho biteganyijwe ko mu 2026 uzaba wagejejwe ku isoko.

BioNTech yavuze ko izatangira gushyira ku isoko umuti wa kanseri mu 2026

Kwamamaza

Kwamamaza

Kwamamaza

TANGA IGITEKEREZO

AMATEGEKO AGENGA IYANDIKA RY'IGITEKEREZO CYAWE
Kwamamaza

Special pages
. . . . . .